Mueller T C, Kowalski A, Sørensen M. "Method for the Synthesis of Teneligliptin Impurity 43" [P]. European Patent, EP 3361084 A1, 2025-07-21.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 替格列汀杂质43 in Pharmaceutical Formulations". Chemosphere, 2014, 2248, 9505-9511.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替格列汀杂质43 as an Impurity". Biomed. Chromatogr., 2013, 539, 2393-2418.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Teneligliptin Impurity 43 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2016, 211, 4421-4441.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 替格列汀杂质43 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2015, 946, 47-66.